Sri Lanka Probes Shipments Of Outdated Platelets To Hospitals
This article was originally published in PharmAsia News
Executive Summary
The Health Ministry of Sri Lanka has ordered an investigation to determine how outdated kits of blood platelets were shipped to key hospitals in the country. The probe was prompted by the discovery of 30 of the outdated kits at the Anuradhapura Teaching Hospital. The head of the hospital said it was not possible that outdated platelets were used in the hospital's blood transfusions. But the head of the Health Ministry assigned high-ranking officials of the country's Blood Transfusion Centre to find the responsible parties. (Click here for more
You may also be interested in...
‘Parity To The Originator Is Not Enough’ – Cardinal Health Talks US Biosimilars
Following what Cardinal Health described as “a year of monumental developments in biosimilars,” the firm’s director of biosimilars, Dracey Poore, spoke to Generics Bulletin for an exclusive Q&A.
Fresenius And Formycon Strike Stelara Settlement For Europe And Canada
Partners Fresenius Kabi and Formycon have laid the groundwork to launch their biosimilar ustekinumab rival to Stelara in Europe and Canada through a settlement agreement with originator J&J.
Sumitomo To Reprioritize Pipeline After Ulotaront’s Phase III Fail
Sumitomo Pharma is to focus more on late-stage candidates in oncology and cell/gene therapy while passing on full global rights for ulotaront and SEP-380135 to Otsuka.